These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22936342)

  • 1. Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradation.
    Shimizu K; Taniyama Y; Sanada F; Azuma J; Iwabayashi M; Iekushi K; Rakugi H; Morishita R
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2687-93. PubMed ID: 22936342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells.
    Sanada F; Taniyama Y; Iekushi K; Azuma J; Okayama K; Kusunoki H; Koibuchi N; Doi T; Aizawa Y; Morishita R
    Circ Res; 2009 Sep; 105(7):667-75, 13 p following 675. PubMed ID: 19713535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model.
    Obama T; Tsuji T; Kobayashi T; Fukuda Y; Takayanagi T; Taro Y; Kawai T; Forrester SJ; Elliott KJ; Choi E; Daugherty A; Rizzo V; Eguchi S
    Clin Sci (Lond); 2015 May; 128(9):559-65. PubMed ID: 25531554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide induces VCAM-1 expression and neutrophil adhesion to human tracheal smooth muscle cells: involvement of Src/EGFR/PI3-K/Akt pathway.
    Lin WN; Luo SF; Wu CB; Lin CC; Yang CM
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):256-68. PubMed ID: 18182168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
    Meng D; Shi X; Jiang BH; Fang J
    Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.
    Donev IS; Wang W; Yamada T; Li Q; Takeuchi S; Matsumoto K; Yamori T; Nishioka Y; Sone S; Yano S
    Clin Cancer Res; 2011 Apr; 17(8):2260-9. PubMed ID: 21220474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel phosphoinositide 3-kinase-mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factor.
    Sano T; Takeuchi S; Nakagawa T; Ishikawa D; Nanjo S; Yamada T; Nakamura T; Matsumoto K; Yano S
    Int J Cancer; 2013 Jul; 133(2):505-13. PubMed ID: 23319394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms.
    Peña-Silva RA; Chalouhi N; Wegman-Points L; Ali M; Mitchell I; Pierce GL; Chu Y; Ballas ZK; Heistad D; Hasan D
    Hypertension; 2015 Mar; 65(3):587-93. PubMed ID: 25510828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
    Takeuchi S; Wang W; Li Q; Yamada T; Kita K; Donev IS; Nakamura T; Matsumoto K; Shimizu E; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
    Am J Pathol; 2012 Sep; 181(3):1034-43. PubMed ID: 22789825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.
    Takayanagi T; Kawai T; Forrester SJ; Obama T; Tsuji T; Fukuda Y; Elliott KJ; Tilley DG; Davisson RL; Park JY; Eguchi S
    Hypertension; 2015 Jun; 65(6):1349-55. PubMed ID: 25916723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET.
    Zhou JY; Chen X; Zhao J; Bao Z; Chen X; Zhang P; Liu ZF; Zhou JY
    Cancer Lett; 2014 Sep; 351(2):265-71. PubMed ID: 24983493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancer.
    Yamada T; Takeuchi S; Kita K; Bando H; Nakamura T; Matsumoto K; Yano S
    J Thorac Oncol; 2012 Feb; 7(2):272-80. PubMed ID: 22089117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of epidermal growth factor receptor attenuates LPS-induced inflammation and acute lung injury in rats.
    Shan X; Zhang Y; Chen H; Dong L; Wu B; Xu T; Hu J; Liu Z; Wang W; Wu L; Feng Z; Liang G
    Oncotarget; 2017 Apr; 8(16):26648-26661. PubMed ID: 28460454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth.
    Zhang YW; Staal B; Essenburg C; Su Y; Kang L; West R; Kaufman D; Dekoning T; Eagleson B; Buchanan SG; Vande Woude GF
    Cancer Res; 2010 Sep; 70(17):6880-90. PubMed ID: 20643778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.
    Nagareddy PR; MacLeod KM; McNeill JH
    Cardiovasc Res; 2010 Jul; 87(1):177-86. PubMed ID: 20110336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp90 inhibition overcomes HGF-triggering resistance to EGFR-TKIs in EGFR-mutant lung cancer by decreasing client protein expression and angiogenesis.
    Koizumi H; Yamada T; Takeuchi S; Nakagawa T; Kita K; Nakamura T; Matsumoto K; Suda K; Mitsudomi T; Yano S
    J Thorac Oncol; 2012 Jul; 7(7):1078-85. PubMed ID: 22592212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells.
    Shimizu H; Hirose Y; Goto S; Nishijima F; Zrelli H; Zghonda N; Niwa T; Miyazaki H
    Life Sci; 2012 Sep; 91(5-6):172-7. PubMed ID: 22781707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling.
    Zwaenepoel K; Goris J; Erneux C; Parker PJ; Janssens V
    FASEB J; 2010 Feb; 24(2):538-47. PubMed ID: 19825976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
    Coquerel D; Neviere R; Delile E; Mulder P; Marechal X; Montaigne D; Renet S; Remy-Jouet I; Gomez E; Henry JP; do Rego JC; Richard V; Tamion F
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1032-44. PubMed ID: 24578383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.